These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 7481245)
1. [Estrogens following menopause. Methods of hormone replacement]. Robyn C Rev Med Brux; 1995; 16(4):291-4. PubMed ID: 7481245 [TBL] [Abstract][Full Text] [Related]
2. Use of menopausal hormones in the United States, 1992 through June, 2003. Wysowski DK; Governale LA Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701 [TBL] [Abstract][Full Text] [Related]
3. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study. Dew JE; Wren BG; Eden JA Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110 [TBL] [Abstract][Full Text] [Related]
4. Guidelines for hormone treatment of women in the menopausal transition and beyond. Naftolin F; Schneider HP; Sturdee DW; Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104 [No Abstract] [Full Text] [Related]
5. Estrogen effects on neuroendocrine function: the new challenge of pulsed therapy. Genazzani AR; Bernardi F Climacteric; 2002 Jun; 5 Suppl 2():50-6. PubMed ID: 12482112 [TBL] [Abstract][Full Text] [Related]
6. Update on continuous estrogen-progestin replacement therapy. Rosenfeld JA Am Fam Physician; 1994 Nov; 50(7):1519-23, 1527-8. PubMed ID: 7976988 [TBL] [Abstract][Full Text] [Related]
7. Current trends in hormone replacement therapy. Khashoggi TY Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567 [TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer. Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929 [TBL] [Abstract][Full Text] [Related]
9. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
10. Menopausal hormones and risk of ovarian cancer. Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062 [TBL] [Abstract][Full Text] [Related]
13. Treatment options and menopause regimens. Farrell E Aust Fam Physician; 1992 Mar; 21(3):240-6. PubMed ID: 1605762 [TBL] [Abstract][Full Text] [Related]
14. [Hormone therapy and risk for venous thromboembolism in postmenopausal women]. Lacut K; Oger E Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617 [TBL] [Abstract][Full Text] [Related]
15. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women. Lacroix KA; Bean C; Reilly R; Curran-Celentano J Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774 [TBL] [Abstract][Full Text] [Related]
16. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. Medical Research Council's General Practice Research Framework. BMJ; 1996 Feb; 312(7029):473-8. PubMed ID: 8597678 [TBL] [Abstract][Full Text] [Related]
17. Current hormone replacement therapy: what are the shortcomings? Advances in delivery. Sturdee DW Int J Clin Pract; 1999 Sep; 53(6):468-72. PubMed ID: 10622076 [TBL] [Abstract][Full Text] [Related]
18. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat. Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153 [TBL] [Abstract][Full Text] [Related]